Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fragility Fracture Trial (FFT) – Zoledronic Acid After Non‑Hip, Non‑Vertebral Fragility Fracture
2019-004766-17Phase 4Completed
- Sponsor
- Region Uppsala
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in osteoporosis and fragility fracture comparing Zoledronic acid with Placebo (2 arms). Primary endpoint: Time to new clinical fracture. Started Dec 2020; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosisfragility fracture
Beyond the preview
Go deeper on 2019-004766-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004766-17.